The Intrathecal Morphine for Nephrectomy

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy and the safety of the intrathecal morphine injection in the open nephrectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Meperidine; Morphine

Criteria

Inclusion Criteria:

• Patients scheduled for the open nephrectomy

Exclusion Criteria:

• Patients with renal insufficiency

• Patients with coagulopathy

• History of any neurologic disorder

• History of recent infection in 2 weeks

• History of drug abuse

• Patients who cannot understand the usage of th intravenous patient-controlled analgesia

• Patients using opioids due to the chronic pain